Tag: hypoactive sexual desire dysfunction
![Gender disparity in sexual health options for women: Experts call on pharma and drug regulators to address thumbnail](https://www.lawleypharm.com.au/wp-content/uploads/2019/03/Fotolia_74394526_M.jpg)
Gender disparity in sexual health options for women: Experts call on pharma and drug regulators to address
Posted: August 9, 2019
In 2015 Comment in the prestigious medical journal Lancet Diabetes & Endocrinology by two of the world’s leading female sexual health specialists, Prof…. Continue Reading →
![Hypoactive sexual desire disorder (HSDD) re-defined thumbnail](https://www.lawleypharm.com.au/wp-content/uploads/2019/03/WHO.gif)
Categories: Medical Professional News
Hypoactive sexual desire disorder (HSDD) re-defined
Posted: March 18, 2019
In late 2018 the World Health Organisation (WHO) released an update to The International Classification of Disease (ICD). ICD is a system of medical coding created… Continue Reading →
![Hypoactive Sexual Desire Disorder (HSDD) re-defined thumbnail](https://www.lawleypharm.com.au/wp-content/uploads/2019/03/WHO.gif)
Hypoactive Sexual Desire Disorder (HSDD) re-defined
Posted: March 11, 2019
In late 2018 the World Health Organisation (WHO) released an update to The International Classification of Disease (ICD). ICD is a system of medical coding created… Continue Reading →